The Pentacel™ vaccine is a combination DTaP–HIB/IPV-vaccine, providing protection against 5 diseases in one injection. The FDA approved its use in the U.S. in June, 2008, and it was approved for use as part of the childhood vaccine schedule in October, 2008. It has been used extensively in Europe and Canada for over 10 years with excellent results. It is manufactured by Sanofi Pasteur.
Pentacel can be used at the 2, 4, 6, and 15-18-month vaccinations.
For more information, see the individual vaccine components.
